Exato Technologies Q3 FY26 PAT Surges 191%; Revenue Up 63.23%

TECH
Whalesbook Logo
AuthorSatyam Jha|Published at:
Exato Technologies Q3 FY26 PAT Surges 191%; Revenue Up 63.23%
Overview

Exato Technologies reported robust Q3 FY26 results with PAT surging 191% and revenue growing 63.23% YoY for the nine months. The company is increasingly focusing on international markets, now contributing 28% of revenue, and holds a significant ₹348 crore order book, largely in healthcare. Key risks include high customer concentration and revenue lumpiness, but strategic international expansion and IP development are key growth drivers.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Exato Technologies Charts High Growth Fueled by International Push and Strong Order Book

PAT surged by a striking 191% for the nine months ended December 31, 2025, while revenue recorded a robust 63.23% year-on-year growth.
Reader Takeaway: PAT surged on international revenue growth; high customer concentration remains a key pressure point.

What just happened (today’s filing)

Exato Technologies Limited announced strong results for the third quarter and nine months of FY26, highlighting significant financial and strategic progress. The company reported a 191% surge in Profit After Tax (PAT) and a 63.23% year-on-year increase in revenue for the nine-month period.

Strategically, Exato is enhancing its global footprint, with international revenue now forming 28% of its mix, up from 25% last year, driven by better margins in overseas markets. The company's order book stands robust at ₹348 crore, with a significant concentration of ₹210-220 crore within the healthcare sector.

To accelerate growth, Exato has hired senior leaders from prominent firms like Tata Communication, Infosys, and Oracle to spearhead sales in the US, Australia, and APAC regions. Management projects Q4 FY26 revenue growth of 25-30% and PAT growth of 50-60%, alongside an annual order book increase of 30-40%.

Why this matters

The company's financial performance underscores a successful transition towards higher-margin international markets and the development of its proprietary intellectual property (IP). This strategic shift aims to stabilize and enhance profitability.

The substantial order book, particularly in the healthcare sector, provides clear visibility into future revenue streams and de-risks the company's growth trajectory. The reinforcement of its leadership team signals an ambition for aggressive market penetration and improved execution in key global territories.

The backstory (grounded)

Exato Technologies Limited has been strategically focusing on increasing its international revenue contribution, aiming to capture higher margins from global markets. The company has also been investing in developing proprietary intellectual property (IP) solutions to drive future revenue growth and differentiation.

What changes now

  • Increased contribution from higher-margin international markets is set to improve overall profitability and reduce reliance on domestic revenues.
  • The planned launch of proprietary IP platforms within 6-7 months could diversify revenue streams and reduce dependency on project-based IT services.
  • Hiring seasoned sales leaders suggests a more aggressive push into key global territories like the US and Australia, aiming for enhanced market capture.
  • The company is actively evaluating a SaaS acquisition in San Francisco, signalling potential inorganic growth to boost scale or innovation.
  • Future growth targets include expanding the customer base significantly, from the current 150 to 500-600 clients over the next three years.

Risks to watch

  • Customer Concentration: The top 10 customers contribute a substantial 85-87% of total revenue, posing a significant risk if any major client relationship deteriorates or is lost.
  • Revenue Lumpiness: Large contract sizes, with some deals exceeding ₹100 crore, and extended installation periods can lead to non-linear and unpredictable quarterly revenue growth patterns.
  • Deal Gestation Period: A 6-month delay from deal closure to revenue recognition for subscription-based analytics and cloud deals can impact short-term billing cycles and reported quarterly revenues.

Peer comparison

Exato Technologies operates in a competitive IT services landscape. Peers like Persistent Systems and Happiest Minds Technologies also focus on digital transformation, cloud, and data analytics. While these companies generally show strong growth, Exato's specific emphasis on developing proprietary IP and its concentrated, albeit growing, order book in the healthcare sector offers unique differentiation. However, Exato's high customer concentration remains a more pronounced risk compared to some of its more diversified peers.

Context metrics (time-bound)

  • None available from filing or grounded search.

What to track next

  • Q4 FY26 performance against management's guidance of 25-30% revenue and 50-60% PAT growth.
  • Progress on the launch and revenue generation from the company's proprietary IP platforms.
  • The outcome of the SaaS acquisition evaluation in San Francisco and any potential deal announcements.
  • Conversion of the current ₹348 crore order book, with particular attention to the healthcare segment's contribution.
  • The company's success in expanding its customer base beyond the current 150 clients towards its target of 500-600.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.